Fainting Detection And Early Warning In Syncope Evaluation Study (ARISE)
NCT: NCT07502599 · RECRUITING
Brief Summary
To characterize the impact of orthostatic hypotension (OH) and Vasovagal syncope on signals measured using a wearable Holter monitor in the clinic and ambulatory setting. To evaluate the relationship of signals measured from the Holter monitor with reported symptom severity of orthostatic intolerance per standard data collection, analysis, and questionnaires.
Frequently Asked Questions
What is Fainting Detection And Early Warning In Syncope Evaluation Study (ARISE)?
Fainting Detection And Early Warning In Syncope Evaluation Study (ARISE) is a clinical trial registered under NCT07502599. Current status: RECRUITING.
What is the status of NCT07502599?
The current status of NCT07502599 (Fainting Detection And Early Warning In Syncope Evaluation Study (ARISE)) is: RECRUITING.
When did Fainting Detection And Early Warning In Syncope Evaluation Study (ARISE) start?
Fainting Detection And Early Warning In Syncope Evaluation Study (ARISE) started on 2026-08-06.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.